BML Capital Management as of March 31, 2023
Portfolio Holdings for BML Capital Management
BML Capital Management holds 31 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr Bloomberg 1-3 Mo (BIL) | 15.9 | $18M | 200k | 91.82 | |
| Ishares Tr 0-3 Mnth Treasry (SGOV) | 10.9 | $13M | 125k | 100.58 | |
| Tillys Cl A (TLYS) | 7.7 | $8.9M | 1.2M | 7.71 | |
| Abercrombie & Fitch Cl A (ANF) | 7.1 | $8.2M | 296k | 27.75 | |
| Cyteir Therapeutics | 4.9 | $5.7M | 3.1M | 1.82 | |
| Pardes Biosciences | 4.5 | $5.3M | 4.0M | 1.32 | |
| Adverum Biotechnologies | 4.4 | $5.1M | 7.1M | 0.72 | |
| Eliem Therapeutics (ELYM) | 4.2 | $4.8M | 1.7M | 2.90 | |
| Athira Pharma (ATHA) | 4.0 | $4.7M | 1.9M | 2.50 | |
| Enliven Therapeutics (ELVN) | 4.0 | $4.6M | 212k | 21.90 | |
| Satsuma Pharmaceuticals Ord | 3.9 | $4.5M | 6.4M | 0.70 | |
| Disc Medicine (IRON) | 3.8 | $4.4M | 208k | 21.19 | |
| Talaris Therapeutics | 3.1 | $3.6M | 1.9M | 1.88 | |
| Embark Technology Com New | 3.1 | $3.6M | 1.3M | 2.81 | |
| Metacrine Ord | 3.0 | $3.5M | 6.2M | 0.57 | |
| Oramed Pharmaceuticals Com New (ORMP) | 2.6 | $3.0M | 1.4M | 2.18 | |
| Astrotech Corp (ASTC) | 2.0 | $2.3M | 220k | 10.66 | |
| Jounce Therapeutics | 1.7 | $2.0M | 1.1M | 1.85 | |
| Forte Biosciences (FBRX) | 1.5 | $1.8M | 1.7M | 1.01 | |
| Arca Biopharma (ABIO) | 1.2 | $1.4M | 707k | 1.99 | |
| Carisma Therapeutics (CARM) | 1.1 | $1.3M | 411k | 3.10 | |
| Retractable Technologies (RVP) | 1.0 | $1.2M | 669k | 1.75 | |
| Verrica Pharmaceuticals (VRCA) | 0.8 | $975k | 150k | 6.50 | |
| Surrozen | 0.8 | $899k | 1.5M | 0.60 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $867k | 220k | 3.94 | |
| Lisata Therapeutics (LSTA) | 0.7 | $791k | 244k | 3.25 | |
| Nextcure (NXTC) | 0.4 | $454k | 307k | 1.48 | |
| Graphite Bio | 0.3 | $373k | 152k | 2.45 | |
| Passage Bio (PASG) | 0.3 | $323k | 338k | 0.96 | |
| Adicet Bio (ACET) | 0.1 | $173k | 30k | 5.76 | |
| Neoleukin Therapeutics | 0.0 | $17k | 24k | 0.70 |
